Attila Konya
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study.
Journal: EULAR rheumatology open
Published: June 29, 2026
Target tolerance improvement of the immunogenicity assay developed for analysing samples from clinical trials of RGB-14, a proposed biosimilar to Prolia/Xgeva.
Journal: Journal of immunological methods
Published: January 23, 2025
Physicochemical and Biological Examination of Two Glatiramer Acetate Products.
Journal: Biomedicines
Published: June 05, 2019
Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19-30.https://doi.org/10.1016/j.ensci.2018.05.006.
Journal: eNeurologicalSci
Published: November 09, 2018
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone.
Journal: eNeurologicalSci
Published: April 16, 2018
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model.
Journal: Annals of the New York Academy of Sciences
Published: August 03, 2017
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Journal: Journal of neuroimmunology
Published: September 30, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026